Research ArticleCancer

Noncoding regions are the main source of targetable tumor-specific antigens

See allHide authors and affiliations

Science Translational Medicine  05 Dec 2018:
Vol. 10, Issue 470, eaau5516
DOI: 10.1126/scitranslmed.aau5516

Article Information

vol. 10 no. 470

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication June 21, 2018
  • Accepted for publication November 15, 2018

Author Information

  1. Céline M. Laumont1,2,*,
  2. Krystel Vincent1,2,*,
  3. Leslie Hesnard1,2,
  4. Éric Audemard1,
  5. Éric Bonneil1,
  6. Jean-Philippe Laverdure1,
  7. Patrick Gendron1,
  8. Mathieu Courcelles1,
  9. Marie-Pierre Hardy1,
  10. Caroline Côté1,
  11. Chantal Durette1,
  12. Charles St-Pierre1,2,
  13. Mohamed Benhammadi1,2,
  14. Joël Lanoix1,
  15. Suzanne Vobecky3,
  16. Elie Haddad3,
  17. Sébastien Lemieux1,4,
  18. Pierre Thibault1,5, and
  19. Claude Perreault1,2,,
  1. 1Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec H3C 3J7, Canada.
  2. 2Department of Medicine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.
  3. 3CHU Sainte-Justine, Université de Montréal, Montreal, Quebec H3T 1C5, Canada.
  4. 4Department of Computer Science and Operations Research, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.
  5. 5Department of Chemistry, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.
  1. Corresponding author. Email: claude.perreault{at}umontreal.ca
  • * These authors contributed equally to this work.

  • These authors jointly supervised this work.

Altmetric

Article usage

Article usage: December 2018 to December 2018

AbstractFullPdf
Dec 20180114403463

Navigate This Article